Tag: Anti-Inflammatory Drugs Market trends

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Anti-Inflammatory Drugs Market Poised To Hit $252.87 Billion By 2030 With A 10.6% CAGR

The market size for anti-inflammatory drugs has shown rapid expansion over recent years. This sector is projected to grow from $152.08 billion in 2025 to $168.74 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.0%. The historical growth of this market can be linked to factors such as arthritis prevalence, NSAID usage, hospital prescribing, the burden of autoimmune diseases, and the adoption of steroid therapy.

The anti-inflammatory drugs market size is anticipated to undergo swift expansion over the coming years. This sector is projected to reach $252.87 billion by 2030, displaying a compound annual growth rate (CAGR) of 10.6%. The expansion during the forecast period is attributable to innovation in biologics, the increasing adoption of biosimilars, an aging global population, the rising prevalence of autoimmune diseases, and the integration of precision medicine. Significant developments expected in this period include the wider utilization of biologics and biosimilars, the broadening of treatment options for chronic inflammatory conditions, a movement towards more targeted anti-inflammatory treatments, the development of topical and localized formulations, and a heightened emphasis on long-term safety considerations.

Get A Free Sample Report With In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24465&type=smp&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Anti-Inflammatory Drugs Market Demand Drivers Opening New Revenue Streams

The increasing occurrence of arthritis is anticipated to boost the growth of the anti-inflammatory drugs market in the future. Arthritis is defined as the inflammation of one or more joints, resulting in pain, swelling, and stiffness that can intensify with age. The growing number of arthritis cases is mainly attributed to aging populations, as the natural deterioration of joints increases with age, leading to a higher likelihood of developing arthritis. Anti-inflammatory drugs assist in managing arthritis by diminishing joint inflammation and pain, thereby allowing patients to uphold better mobility and execute daily tasks more effortlessly, ultimately enhancing their overall quality of life. For instance, in July 2024, information from Restored CDC, a US-based nonprofit health information body, indicated that approximately 21.2% of adults aged 18 and older in the US received an arthritis diagnosis in 2023. Thus, the escalating prevalence of arthritis is propelling the expansion of the anti-inflammatory drugs market.

Anti-Inflammatory Drugs Market Segment Analysis And Revenue Potential

The anti-inflammatory drugs market covered in this report is segmented –

1) By Drug Class: Steroids, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Biologics And Biosimilars, Other Drug Classes

2) By Route of Administration: Parenteral, Oral, Topical, Inhalation

3) By Applications: Autoimmune Diseases, Respiratory Diseases, Other Diseases

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Steroids: Corticosteroids, Mineralocorticoids

2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Non-Selective Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Selective Cyclooxygenase-2 (COX-2) Inhibitors

3) By Biologics And Biosimilars: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin (IL) Inhibitors, Janus Kinase (JAK) Inhibitors, Other Biologics And Biosimilars

4) By Other Drug Classes: Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

Anti-Inflammatory Drugs Market Trends Powering Strategic Industry Growth

Major companies in the anti-inflammatory drugs market are focusing on developing innovative solutions, such as advanced corticosteroid alternatives, to meet the increasing demand for safer long-term anti-inflammatory therapies. A next-generation corticosteroid alternative is a treatment engineered to maintain glucocorticoid anti-inflammatory effects while reducing the adverse outcomes commonly associated with traditional steroids, including bone loss, growth suppression, and weight gain. For instance, in October 2023, Santhera Pharmaceuticals, a Switzerland-based specialty pharmaceutical company, received US FDA approval for AGAMREE (vamorolone). AGAMREE is an oral dissociative steroid designed to provide anti-inflammatory activity with fewer steroid-related side effects by selectively modulating glucocorticoid receptor pathways and stabilizing cell membranes. Compared to traditional corticosteroids like prednisone and deflazacort, it offers a more favorable safety profile while retaining therapeutic benefits. It is used to manage chronic muscle inflammation in children aged two years and older with Duchenne muscular dystrophy.

Anti-Inflammatory Drugs Market Key Players Shaping Industry Direction

Major companies operating in the anti-inflammatory drugs market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Gilead Sciences Inc., Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories, Cipla Limited, Cadila Pharmaceuticals, Samsung Bioepis, Lupin Limited

View The Full Anti-Inflammatory Drugs Market Report:

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-drugs-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Anti-Inflammatory Drugs Market Largest Region: Which Geography Holds The Highest Market Share?

North America was the largest region in the anti-inflammatory drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Anti-Inflammatory Drugs Market Forecast: What Market Value Is Expected By 2030?

The market for anti-inflammatory drugs has seen robust expansion in recent times. It is projected to increase from $152.08 billion in 2025 to $168.74 billion in 2026, reflecting an 11.0% compound annual growth rate (CAGR). This historical growth has been driven by factors such as the prevalence of arthritis, widespread use of NSAIDs, prescribing patterns in hospitals, the burden of autoimmune diseases, and the adoption of steroid therapies.

The anti-inflammatory drugs market is projected to experience significant expansion in the coming years, reaching a valuation of $252.87 billion by 2030, driven by a compound annual growth rate (CAGR) of 10.6 percentage points. During the forecast period, this growth is fueled by factors such as innovations in biologic therapies, the increasing penetration of biosimilars, an aging global population, the rising prevalence of autoimmune conditions, and a growing emphasis on precision medicine. Key trends shaping this market include a heightened utilization of biologics and biosimilars, an expansion in the treatment of chronic inflammatory diseases, a transition toward more targeted anti-inflammatory approaches, a surge in topical and localized formulations, and a greater focus on ensuring long-term safety profiles.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24465&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

#Anti-Inflammatory Drugs Market Growth Factors: Which Forces Are Supporting Market Expansion?

The growing occurrence of arthritis is anticipated to fuel the expansion of the market for anti-inflammatory medications in the coming period. Arthritis is defined as the swelling of one or more joints, accompanied by discomfort, puffiness, and rigidity that may intensify over time. This increase in arthritis cases is largely driven by aging demographics, as advancing age leads to greater joint deterioration from natural use, raising the likelihood of contracting the condition. These drugs assist in controlling arthritis by alleviating joint swelling and pain, enabling patients to sustain improved movement and carry out everyday tasks with less difficulty, thereby enhancing their overall life quality. In July 2024, data from Restored CDC, a nonprofit health organization based in the United States, indicated that roughly 21.2% of American adults 18 years and older had been diagnosed with the condition during 2023. As a result, the heightened incidence of arthritis is pushing forward the expansion of the anti-inflammatory drug sector.

Anti-Inflammatory Drugs Market Categorization By Product Type And Application

The anti-inflammatory drugs market covered in this report is segmented –

1) By Drug Class: Steroids, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Biologics And Biosimilars, Other Drug Classes

2) By Route of Administration: Parenteral, Oral, Topical, Inhalation

3) By Applications: Autoimmune Diseases, Respiratory Diseases, Other Diseases

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Steroids: Corticosteroids, Mineralocorticoids

2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Non-Selective Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Selective Cyclooxygenase-2 (COX-2) Inhibitors

3) By Biologics And Biosimilars: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin (IL) Inhibitors, Janus Kinase (JAK) Inhibitors, Other Biologics And Biosimilars

4) By Other Drug Classes: Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

Anti-Inflammatory Drugs Market Industry Trends: What Changes Are Reshaping Demand?

Leading market players in the anti-inflammatory drugs sector are channeling efforts into creating pioneering therapies, particularly advanced corticosteroid alternatives, to fulfill the increasing need for safer, long-term anti-inflammatory treatments. A cutting-edge corticosteroid alternative represents a therapeutic approach engineered to preserve the glucocorticoid-mediated anti-inflammatory benefits while mitigating common side effects of traditional steroids, such as bone density reduction, hindered growth, and increased body weight. In October 2023, for example, Santhera Pharmaceuticals, a specialty pharmaceutical firm headquartered in Switzerland, obtained FDA approval in the United States for AGAMREE (vamorolone). This oral dissociative steroid is formulated to provide anti-inflammatory effects while minimizing steroid-associated adverse events, achieved through selective modulation of glucocorticoid receptor pathways and the stabilization of cell membranes. When compared to conventional corticosteroids like prednisone and deflazacort, it exhibits an improved safety profile without compromising therapeutic efficacy. The medication is indicated for managing chronic muscle inflammation in children aged two years and older suffering from Duchenne muscular dystrophy.

Anti-Inflammatory Drugs Market Company Landscape And Strategic Competition

Major companies operating in the anti-inflammatory drugs market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Gilead Sciences Inc., Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories, Cipla Limited, Cadila Pharmaceuticals, Samsung Bioepis, Lupin Limited

Access The Complete Anti-Inflammatory Drugs Market Report:

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-drugs-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Anti-Inflammatory Drugs Market Largest Region By Revenue And Market Share

North America was the largest region in the anti-inflammatory drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Growth In Market Value Is Expected For The Anti-Inflammatory Drugs Market Between 2026 And 2030?

The anti-inflammatory drugs market has experienced substantial growth in recent years. This market is projected to expand from $152.08 billion in 2025 to $168.74 billion in 2026, reflecting a compound annual growth rate (CAGR) of 11.0%. The expansion observed in prior periods is attributable to factors such as arthritis prevalence, NSAID usage, hospital prescribing practices, the increasing burden of autoimmune diseases, and the widespread adoption of steroid therapy.

The anti-inflammatory drugs market size is anticipated to experience substantial expansion in the upcoming years. It is projected to reach $252.87 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.6%. The expansion observed during this forecast period can be linked to advancements such as biologic innovation, increased biosimilar penetration, an aging global population, the rising prevalence of autoimmune diseases, and the embrace of precision medicine. Prominent trends for the forecast period include the expanding utilization of biologics and biosimilars, a wider array of chronic inflammatory disease treatments, a pivot towards more targeted anti-inflammatory therapies, the growth of topical and localized drug formulations, and an intensified focus on long-term safety aspects.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24465&type=smp

What Key Factors Are Shaping The Anti-Inflammatory Drugs Market Landscape?

The increasing occurrence of arthritis is projected to boost expansion within the anti-inflammatory drugs market moving ahead. Arthritis is characterized by the inflammation of one or more joints, leading to pain, swelling, and stiffness that may intensify over time. This rise in arthritis cases is largely attributed to aging demographics; as individuals age, the natural deterioration of joints advances, significantly raising the probability of developing the condition. Anti-inflammatory medications assist in managing arthritis by alleviating joint inflammation and discomfort, thereby enabling patients to sustain improved mobility and execute everyday tasks more comfortably, consequently enhancing their overall quality of life. For example, data from July 2024, provided by Restored CDC, a US-based nonprofit health information organization, showed that approximately 21.2% of adults aged 18 and older in the US had an arthritis diagnosis in 2023. Consequently, the growing incidence of arthritis is a key factor propelling the expansion of the anti-inflammatory drugs market.

How Are Different Segments Classified In The Anti-Inflammatory Drugs Market Segment Analysis?

The anti-inflammatory drugs market covered in this report is segmented –

1) By Drug Class: Steroids, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Biologics And Biosimilars, Other Drug Classes

2) By Route of Administration: Parenteral, Oral, Topical, Inhalation

3) By Applications: Autoimmune Diseases, Respiratory Diseases, Other Diseases

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Steroids: Corticosteroids, Mineralocorticoids

2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Non-Selective Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Selective Cyclooxygenase-2 (COX-2) Inhibitors

3) By Biologics And Biosimilars: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin (IL) Inhibitors, Janus Kinase (JAK) Inhibitors, Other Biologics And Biosimilars

4) By Other Drug Classes: Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

What Trends Are Affecting The Growth Of The Anti-Inflammatory Drugs Market?

Key companies in the anti-inflammatory drugs market are concentrating on developing innovative solutions, such as next-generation corticosteroid alternatives, to satisfy the increasing demand for safer long-term anti-inflammatory treatments. These next-generation corticosteroid alternatives are therapies engineered to maintain glucocorticoid anti-inflammatory effects while minimizing adverse outcomes often linked with traditional steroids, including bone loss, growth suppression, and weight gain. As an illustration, in October 2023, Santhera Pharmaceuticals, a Switzerland-based specialty pharmaceutical company, obtained US FDA approval for AGAMREE (vamorolone). AGAMREE is an oral dissociative steroid designed to deliver anti-inflammatory activity with reduced steroid-related side effects by selectively modulating glucocorticoid receptor pathways and stabilizing cell membranes. Compared to conventional corticosteroids such as prednisone and deflazacort, it provides a more favorable safety profile while preserving therapeutic benefits. It is used for the management of chronic muscle inflammation in children aged two years and older who have Duchenne muscular dystrophy.

Who Are The Companies Driving Activity In The Anti-Inflammatory Drugs Market?

Major companies operating in the anti-inflammatory drugs market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Gilead Sciences Inc., Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories, Cipla Limited, Cadila Pharmaceuticals, Samsung Bioepis, Lupin Limited

Get The Full Anti-Inflammatory Drugs Market Report:

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-drugs-global-market-report

Which Region Is The Leading Market For The Anti-Inflammatory Drugs Market?

North America was the largest region in the anti-inflammatory drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Anti-Inflammatory Drugs Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-drugs-global-market-report

Browse Through More Reports Similar to the Global Anti-Inflammatory Drugs Market 2026, By The Business Research Company

Rheumatology Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/rheumatology-therapeutics-global-market-report

Non Steroidal Anti Inflammatory Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/non-steroidal-anti-inflammatory-drugs-global-market-report

Rare Inflammatory Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-inflammatory-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Anti-Inflammatory Drugs Market Across 2026–2030?

The anti-inflammatory drugs market size has experienced significant growth over recent years. The market is anticipated to increase from $152.08 billion in 2025 to $168.74 billion in 2026, with a compound annual growth rate (CAGR) of 11.0%. Factors contributing to its historical growth include arthritis prevalence, nsaid usage, hospital prescribing, autoimmune disease burden, and steroid therapy adoption.

The anti-inflammatory drugs market is projected for substantial expansion in the coming years, reaching a valuation of $252.87 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.6%. This anticipated growth during the forecast period is driven by factors such as advancements in biologics, increased penetration of biosimilars, an expanding aging population, a rise in autoimmune diseases, and the adoption of precision medicine. Key trends expected over the forecast horizon encompass the expanding application of biologics and biosimilars, broader treatment options for chronic inflammatory conditions, a move towards more targeted anti-inflammatory treatments, an increase in topical and localized drug formulations, and a heightened emphasis on long-term safety considerations.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24465&type=smp

What Primary Drivers Are Shaping The Development Of The Anti-Inflammatory Drugs Market?

The increasing prevalence of arthritis is anticipated to propel the expansion of the anti-inflammatory drugs market moving forward. Arthritis is defined as the inflammation of one or more joints, resulting in pain, swelling, and stiffness that can worsen with advancing age. The heightened occurrence of arthritis is primarily due to aging populations; as individuals grow older, the natural wear and tear on their joints intensifies, leading to a greater likelihood of developing arthritis. Anti-inflammatory drugs assist in managing arthritis by diminishing joint inflammation and pain, enabling patients to sustain better mobility and perform daily activities with enhanced ease, ultimately elevating their overall quality of life. For example, in July 2024, according to Restored CDC, a US-based nonprofit health information body, approximately 21.2% of adults aged 18 and older in the US were diagnosed with arthritis in 2023. Consequently, the rising prevalence of arthritis is fueling the growth of the anti-inflammatory drugs market.

What Segmentation Levels Are Considered In The Anti-Inflammatory Drugs Market?

The anti-inflammatory drugs market covered in this report is segmented –

1) By Drug Class: Steroids, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Biologics And Biosimilars, Other Drug Classes

2) By Route of Administration: Parenteral, Oral, Topical, Inhalation

3) By Applications: Autoimmune Diseases, Respiratory Diseases, Other Diseases

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Steroids: Corticosteroids, Mineralocorticoids

2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Non-Selective Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Selective Cyclooxygenase-2 (COX-2) Inhibitors

3) By Biologics And Biosimilars: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin (IL) Inhibitors, Janus Kinase (JAK) Inhibitors, Other Biologics And Biosimilars

4) By Other Drug Classes: Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

What Trends Are Projected To Affect The Anti-Inflammatory Drugs Market?

Leading firms operating in the anti-inflammatory drugs market are concentrating on creating novel solutions, including advanced corticosteroid alternatives, to satisfy the growing need for safer anti-inflammatory treatments over extended periods. Such next-generation corticosteroid alternatives are therapies designed to maintain glucocorticoid anti-inflammatory efficacy while minimizing common side effects of conventional steroids, such as bone density loss, stunted growth, and increased weight. As an illustration, Santhera Pharmaceuticals, a Switzerland-based specialty pharmaceutical company, secured US FDA approval for AGAMREE (vamorolone) in October 2023. AGAMREE is an oral dissociative steroid crafted to provide anti-inflammatory action with fewer steroid-associated adverse effects by selectively influencing glucocorticoid receptor pathways and stabilizing cellular membranes. It presents a superior safety profile compared to conventional corticosteroids such as prednisone and deflazacort, while still delivering therapeutic advantages. This medication is prescribed for managing chronic muscle inflammation in children aged two years and older who have Duchenne muscular dystrophy.

Which Leading Firms Are Contributing To The Growth Of The Anti-Inflammatory Drugs Market?

Major companies operating in the anti-inflammatory drugs market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Gilead Sciences Inc., Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories, Cipla Limited, Cadila Pharmaceuticals, Samsung Bioepis, Lupin Limited

Read the full anti-inflammatory drugs market report here:

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-drugs-global-market-report

How Does The Anti-Inflammatory Drugs Market Perform Across Major Global Regions?

North America was the largest region in the anti-inflammatory drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Anti-Inflammatory Drugs Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24465&type=smp

Browse Through More Reports Similar to the Global Anti-Inflammatory Drugs Market 2026, By The Business Research Company

Rheumatology Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/rheumatology-therapeutics-global-market-report

Non Steroidal Anti Inflammatory Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/non-steroidal-anti-inflammatory-drugs-global-market-report

Rare Inflammatory Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-inflammatory-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the anti-inflammatory drugs market from 2026–2035 with trusted insights from The Business Research Company

What is the estimated market size of the Anti-Inflammatory Drugs Market by the end of 2030?

The anti-inflammatory drugs market size has experienced significant expansion in recent years. This market is projected to grow from $152.08 billion in 2025 to $168.74 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.0%. The increase observed in previous periods stems from factors such as arthritis prevalence, nsaid usage, hospital prescribing, the burden of autoimmune diseases, and the adoption of steroid therapy.

The anti-inflammatory drugs market size is anticipated to undergo significant expansion over the next few years, with projections indicating it will reach $252.87 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.6%. This growth during the forecast period is attributable to innovations in biologics, increased penetration of biosimilars, an aging population, the growing prevalence of autoimmune diseases, and the adoption of precision medicine. Noteworthy trends for the forecast period include the expanding use of biologics and biosimilars, the broadening of treatments for chronic inflammatory diseases, a shift towards more targeted anti-inflammatory therapies, an increase in topical and localized formulations, and a greater emphasis on long-term safety.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24465&type=smp

What Drivers Are Shaping Future Opportunities In The Anti-Inflammatory Drugs Market?

The growing occurrence of arthritis is anticipated to boost the expansion of the anti-inflammatory drugs market in the foreseeable future. Arthritis is defined as the inflammation of multiple joints, leading to discomfort, swelling, and rigidity that tends to intensify with advancing age. The increased incidence of arthritis largely stems from aging demographics; as individuals age, the natural deterioration of joints rises, leading to a greater probability of developing the condition. Anti-inflammatory medications assist in managing arthritis by alleviating joint inflammation and pain, thereby enabling patients to sustain improved mobility and conduct daily tasks more readily, ultimately enhancing their general well-being. For example, data from July 2024, provided by Restored CDC, a US-based nonprofit health information organization, indicated that approximately 21.2% of adults aged 18 and older in the US received an arthritis diagnosis in 2023. Consequently, the increasing prevalence of arthritis is fueling the growth of the anti-inflammatory drugs market.

Which Segments Are Gaining Traction In The Anti-Inflammatory Drugs Market?

The anti-inflammatory drugs market covered in this report is segmented –

1) By Drug Class: Steroids, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Biologics And Biosimilars, Other Drug Classes

2) By Route of Administration: Parenteral, Oral, Topical, Inhalation

3) By Applications: Autoimmune Diseases, Respiratory Diseases, Other Diseases

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Steroids: Corticosteroids, Mineralocorticoids

2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Non-Selective Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Selective Cyclooxygenase-2 (COX-2) Inhibitors

3) By Biologics And Biosimilars: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin (IL) Inhibitors, Janus Kinase (JAK) Inhibitors, Other Biologics And Biosimilars

4) By Other Drug Classes: Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

What Upcoming Trends Are Likely To Define The Future Path Of The Anti-Inflammatory Drugs Market?

Leading companies in the anti-inflammatory drugs market are concentrating on developing innovative solutions, such as next-generation corticosteroid alternatives, to address the increasing need for safer, long-term anti-inflammatory treatments. These advanced corticosteroid alternatives are therapies engineered to maintain glucocorticoid anti-inflammatory effects while mitigating common adverse outcomes associated with traditional steroids, including bone loss, growth suppression, and weight gain. For instance, in October 2023, Santhera Pharmaceuticals, a Switzerland-based specialty pharmaceutical company, obtained US FDA approval for AGAMREE (vamorolone). AGAMREE is an oral dissociative steroid crafted to provide anti-inflammatory activity with reduced steroid-related side effects by selectively modulating glucocorticoid receptor pathways and stabilizing cell membranes. Compared to conventional corticosteroids such as prednisone and deflazacort, it presents a more advantageous safety profile while retaining its therapeutic benefits. It is utilized for managing chronic muscle inflammation in children aged two years and older who have Duchenne muscular dystrophy.

Who Are The Primary Competitors In The Global Anti-Inflammatory Drugs Market?

Major companies operating in the anti-inflammatory drugs market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Gilead Sciences Inc., Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories, Cipla Limited, Cadila Pharmaceuticals, Samsung Bioepis, Lupin Limited

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-drugs-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Anti-Inflammatory Drugs Market?

North America was the largest region in the anti-inflammatory drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Anti-Inflammatory Drugs Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24465&type=smp

Browse Through More Reports Similar to the Global Anti-Inflammatory Drugs Market 2026, By The Business Research Company

Rheumatology Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/rheumatology-therapeutics-global-market-report

Non Steroidal Anti Inflammatory Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/non-steroidal-anti-inflammatory-drugs-global-market-report

Rare Inflammatory Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-inflammatory-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Anti-Inflammatory Drugs Market By 2029?

The market for anti-inflammatory drugs has experienced rapid expansion in recent years. Its value is projected to increase from $136.86 billion in 2024 to $152.08 billion in 2025, achieving a compound annual growth rate (CAGR) of 11.1%. The growth observed in the past can be ascribed to factors like a progressively aging population, the escalating prevalence of chronic inflammatory conditions, greater accessibility of over-the-counter medications, increasing understanding of pain management, and the broader development of healthcare infrastructure.

The anti-inflammatory drugs market is projected to experience substantial expansion over the next few years. It is forecast to grow to $228.83 billion by 2029, achieving a compound annual growth rate (CAGR) of 10.8%. This growth during the forecast period is primarily driven by factors such as the rising incidence of autoimmune diseases, increasing demand for personalized medicine, an expanding geriatric population, supportive government initiatives, and a growing preference for topical and targeted therapies. Prominent trends expected in this period include innovations in biologic drugs, a strategic shift towards biologics and biosimilars, the rise of telemedicine prescriptions, the integration of AI in drug discovery, ongoing R&D in novel anti-inflammatory mechanisms, and continued innovation in targeted anti-inflammatory therapies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24465&type=smp

Which Industry Drivers Are Expected To Accelerate The Anti-Inflammatory Drugs Market From 2025 To 2029?

The increasing occurrence of arthritis is projected to propel the expansion of the anti-inflammatory drugs market in the coming years. Arthritis is defined as the inflammation of one or more joints, manifesting as pain, swelling, and stiffness that typically worsens with age. The growing incidence of arthritis is primarily attributed to aging populations; as individuals grow older, the natural wear and tear on joints increases, leading to a greater likelihood of developing the condition. Anti-inflammatory drugs assist in managing arthritis by alleviating joint inflammation and pain, enabling patients to maintain better mobility and perform daily activities with greater ease, thereby enhancing their overall quality of life. For instance, in March 2023, according to the Office for Health Improvement and Disparities, a UK-based government department, in 2022, 17.6% of individuals aged 16 and older reported having a long-term musculoskeletal (MSK) condition, such as arthritis or a persistent back or joint issue, which rose from 17.0% in 2021. Therefore, the rising prevalence of arthritis is a key driver for the growth of the anti-inflammatory drugs market.

What Are The Emerging Segments Gaining Attention In The Anti-Inflammatory Drugs Market?

The anti-inflammatory drugs market covered in this report is segmented –

1) By Drug Class: Steroids, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Biologics And Biosimilars, Other Drug Classes

2) By Route of Administration: Parenteral, Oral, Topical, Inhalation

3) By Applications: Autoimmune Diseases, Respiratory Diseases, Other Diseases

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Steroids: Corticosteroids, Mineralocorticoids

2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Non-Selective Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Selective Cyclooxygenase-2 (COX-2) Inhibitors

3) By Biologics And Biosimilars: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin (IL) Inhibitors, Janus Kinase (JAK) Inhibitors, Other Biologics And Biosimilars

4) By Other Drug Classes: Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants, Antihistamines

What Trends Are Redefining The Anti-Inflammatory Drugs Market Dynamics?

Major companies operating in the anti-inflammatory drugs market are prioritizing the creation of advanced formulations, such as topical solutions, to facilitate precise delivery and improve patient adherence. A topical solution, which is a liquid medicine applied directly to the skin or the affected region, aids anti-inflammatory medications by locally delivering their active components, thereby alleviating inflammation at the site while mitigating systemic adverse effects. For instance, in December 2022, Lupin Limited, an India-based pharmaceutical company, introduced the approved generic equivalent of PENNSAID (Diclofenac Sodium Topical Solution, 2% w/w) from Horizon Pharma Therapeutics in the United States. This initiative aimed to broaden its U.S. generics portfolio and enhance access to economical anti-inflammatory treatments. This particular drug, classified as a nonsteroidal anti-inflammatory medication, is employed to manage pain associated with osteoarthritis of the knee, providing localized relief through its topical application and reducing the systemic side effects often associated with oral NSAIDs.

Who Are The Top Performing Companies In The Anti-Inflammatory Drugs Market In Recent Years?

Major companies operating in the anti-inflammatory drugs market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Gilead Sciences Inc., Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories, Cipla Limited, Cadila Pharmaceuticals, Samsung Bioepis, Lupin Limited

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-drugs-global-market-report

What Regional Growth Trends Are Shaping The Anti-Inflammatory Drugs Market Outlook?

North America was the largest region in the anti-inflammatory drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Anti-Inflammatory Drugs Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24465&type=smp

Browse Through More Reports Similar to the Global Anti-Inflammatory Drugs Market 2025, By The Business Research Company

Veterinary Orthopedic Medicine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-orthopedic-medicine-global-market-report

Pediatric Orthopedic Implants Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pediatric-orthopedic-implants-global-market-report

Orthopedic Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/orthopedic-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Forecasted Growth Rate and Market Size of the Anti-Inflammatory Drugs Market?

The market size for anti-inflammatory drugs has seen a fast-paced growth lately. From $136.86 billion in 2024, the market is anticipated to expand to $152.08 billion in 2025, achieving a compound annual growth rate (CAGR) of 11.1%. The rapid growth seen in history can be associated with several factors including a growing senior population, a rising occurrence of chronic inflammation-related diseases, an increase in over-the-counter accessibility, heightened recognition of pain management, and the growth of overall healthcare infrastructure.

The market for anti-inflammatory drugs is anticipated to experience substantial expansion in the coming years, reaching $228.83 billion by 2029 with a compound annual growth rate (CAGR) of 10.8%. The anticipated growth during this forecast period is attributed to factors such as the rising prevalence of autoimmune diseases, an increasing demand for individualized medicine, a growing elderly population, supportive governmental initiatives, and an increased preference for topical and targeted treatments. Future trends expected to impact the market during this period include innovations in biologic drugs, a shift towards biologics and biosimilars, telemedicine prescriptions, AI integration in drug discovery, research and development in new anti-inflammatory mechanisms, and advancements in targeted anti-inflammatory therapies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24465&type=smp

Which Factor Is Shaping The Future Of The Anti-Inflammatory Drugs Market?

The growth of the anti-inflammatory drugs market is expected to be stimulated by the rising prevalence of arthritis. Arthritis includes the inflammation of one or more joints, which can lead to pain, swelling, and stiffness that often intensifies with age. This increase in arthritis cases is primarily associated with an aging population since as people grow older, they naturally experience more wear and tear on their joints, which increases the risk of arthritis. Anti-inflammatory medications are crucial in addressing arthritis as they lessen joint inflammation and pain, improving patients’ mobility and making daily activities easier, thereby enhancing their overall life quality. For example, the Office for Health Improvement and Disparities, a UK-based government department, released data in March 2023 stating that in 2022, 17.6% of people aged 16 and above reported long-term musculoskeletal (MSK) conditions like arthritis or continuous back or joint problems. This was an increase from 17.0% in 2021. Consequently, the increasing occurrence of arthritis is fuelling the expansion of the anti-inflammatory drugs market.

What Is The Segment-Wise Breakdown Of The Anti-Inflammatory Drugs Market?

The anti-inflammatory drugs market covered in this report is segmented –

1) By Drug Class: Steroids, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Biologics And Biosimilars, Other Drug Classes

2) By Route of Administration: Parenteral, Oral, Topical, Inhalation

3) By Applications: Autoimmune Diseases, Respiratory Diseases, Other Diseases

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Steroids: Corticosteroids, Mineralocorticoids

2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Non-Selective Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Selective Cyclooxygenase-2 (COX-2) Inhibitors

3) By Biologics And Biosimilars: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin (IL) Inhibitors, Janus Kinase (JAK) Inhibitors, Other Biologics And Biosimilars

4) By Other Drug Classes: Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants, Antihistamines

Which Trends Are Redefining The Future Landscape Of The Anti-Inflammatory Drugs Industry?

The focus has shifted towards the creation of groundbreaking topical solutions within the anti-inflammatory drugs market, with numerous prominent firms endeavoring to enhance targeted delivery and patient adherence. A topical solution, which is a liquid-based medication applied right to the skin or affected region, streamlines the delivery of active elements of the anti-inflammatory drugs, reducing inflammation on-site while limiting the systemic side effects. In an illustrative case in December 2022, Lupin Limited, an Indian pharmaceutical firm, launched the authorized generic equivalent of PENNSAID (Diclofenac Sodium Topical Solution, 2% w/w) manufactured by Horizon Pharma Therapeutics, in the United States. This was aimed at boosting its U.S. generic range and augmenting the availability of reasonably priced anti-inflammatory remedies. This non-steroidal anti-inflammatory drug, meant to alleviate osteoarthritis-related knee pain, affords localized relief upon topical application and circumscribes systemic complications commonplace with orally administered NSAIDs.

Which Companies Hold The Largest Market Share In The Anti-Inflammatory Drugs Sector?

Major companies operating in the anti-inflammatory drugs market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Gilead Sciences Inc., Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories, Cipla Limited, Cadila Pharmaceuticals, Samsung Bioepis, Lupin Limited

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-drugs-global-market-report

How Does Regional Performance Compare Across The Anti-Inflammatory Drugs Industry?

North America was the largest region in the anti-inflammatory drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24465&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Anti-Inflammatory Drugs Market?

The market size of anti-inflammatory drugs has seen a swift expansion in recent years, escalating from $136.86 billion in 2024 to an estimated $152.08 billion in 2025 with a compound annual growth rate (CAGR) of 11.1%. The factors responsible for this growth in the historical timeline include an aging population, a high incidence of chronic inflammatory diseases, expanded over-the-counter accessibility, a surge in knowledge regarding pain management, and the growth of healthcare infrastructure.

What Growth Rate Is Forecasted for the Anti-Inflammatory Drugs Market by 2029?

The market size for anti-inflammatory drugs is forecasted to experience a swift expansion in the coming years. By 2029, the market is predicted to reach a value of $228.83 billion, with a compound annual growth rate (CAGR) of 10.8%. This projected growth within the predicted period can be credited to a rise in autoimmune disease prevalence, the growing demand for personalized medication, an increase in the elderly population, government initiatives in support, and a heightened preference for targeted and topical therapies. Key trends expected within this period encompass development in biologic drugs, a trend towards biologics and biosimilars, prescriptions via telemedicine, the use of AI in drug discovery, research, and development into new anti-inflammatory mechanisms, along with innovations in targeted anti-inflammatory treatments.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24465&type=smp

Which Key Companies Are Shaping the Future of the Anti-Inflammatory Drugs Market?

Major companies operating in the anti-inflammatory drugs market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Gilead Sciences Inc., Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories, Cipla Limited, Cadila Pharmaceuticals, Samsung Bioepis, Lupin Limited

Which Factors Are Driving Demand in the Anti-Inflammatory Drugs Industry?

The increasing incidence of arthritis is anticipated to fuel the expansion of the anti-inflammatory drugs market in the future. Arthritis is characterized by inflammation in one or more joints, leading to discomfort, swelling, and stiffness that can intensify with age. The escalation in arthritis cases can be primarily attributed to the aging population, as the natural degradation of joints amplifies with age, increasing the probability of arthritis. Anti-inflammatory medications aid in arthritis management by mitigating joint inflammation and pain, enabling patients to retain better mobility and carry out daily tasks more comfortably, thereby enhancing their overall well-being. For example, the Office for Health Improvement and Disparities, a government department in the UK, reported in March 2023 that in 2022, 17.6% of people aged 16 and over informed of having a long-term musculoskeletal (MSK) issue, like arthritis or an ongoing back or joint problem. This figure saw an increase from 17.0% in 2021. Consequently, the increasing incidence of arthritis is driving the expansion of the anti-inflammatory drugs market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24465&type=smp

How Is the Anti-Inflammatory Drugs Market Segmented by Several Divisions?

The anti-inflammatory drugs market covered in this report is segmented –

1) By Drug Class: Steroids, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Biologics And Biosimilars, Other Drug Classes

2) By Route of Administration: Parenteral, Oral, Topical, Inhalation

3) By Applications: Autoimmune Diseases, Respiratory Diseases, Other Diseases

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Steroids: Corticosteroids, Mineralocorticoids

2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Non-Selective Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Selective Cyclooxygenase-2 (COX-2) Inhibitors

3) By Biologics And Biosimilars: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin (IL) Inhibitors, Janus Kinase (JAK) Inhibitors, Other Biologics And Biosimilars

4) By Other Drug Classes: Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants, Antihistamines

What are the Emerging Market Trends Driving the Growth of the Anti-Inflammatory Drugs Industry?

Major firms in the anti-inflammatory drugs market are concentrating their efforts on creating innovative formulations such as a topical solution to provide targeted therapy and enhance patient adherence. Topical solutions are medicines in liquid form that are applied directly onto the skin or the affected region. They assist anti-inflammatory medications by locally delivering the active compounds, decreasing inflammation in the particular area while diminishing overall systemic side effects. Illustrating this point, in December 2022, Lupin Limited, a pharmaceutical company based in India, launched the approved generic version of PENNSAID (Diclofenac Sodium Topical Solution, 2% w/w) from Horizon Pharma Therapeutics in the U.S. This was done to broaden its collection of U.S. generics and increase the availability of cost-effective anti-inflammatory treatments. This nonsteroidal anti-inflammatory drug is employed to alleviate pain caused by knee osteoarthritis, offering local relief through application on skin, whilst reducing the systemic side effects commonly experienced with oral NSAIDs.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-drugs-global-market-report

Which Regions Are Driving Growth in the Anti-Inflammatory Drugs Market?

North America was the largest region in the anti-inflammatory drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24465

This Report Delivers Insight On:

1. How big is the anti-inflammatory drugs market, and how is it changing globally?

2. Who are the major companies in the anti-inflammatory drugs market, and how are they performing?

3. What are the key opportunities and risks in the anti-inflammatory drugs market right now?

4. Which products or customer segments are growing the most in the anti-inflammatory drugs market?

5. What factors are helping or slowing down the growth of the anti-inflammatory drugs market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model